Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine
- 1 January 2007
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 46 (5) , 433-447
- https://doi.org/10.2165/00003088-200746050-00005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory-Depressant Effect of Buprenorphine and Fentanyl in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Allometric relationships between the pharmacokinetics of propofol in rats, children and adultsBritish Journal of Clinical Pharmacology, 2005
- Whole Body Pharmacokinetic ModelsClinical Pharmacokinetics, 2003
- Insights into mu opioid pharmacology: The role of mu opioid receptor subtypesLife Sciences, 2001
- Allometric issues in drug development†Journal of Pharmaceutical Sciences, 1999
- A Size Standard for PharmacokineticsClinical Pharmacokinetics, 1996
- Opioid receptor imaging and displacement studies with [6-O-[11C]methyl]buprenorphine in baboon brainNuclear Medicine and Biology, 1996
- Ligand selectivity of cloned human and rat opioid mu receptorsSynapse, 1995
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- THE PHARMACOLOGICAL DIFFERENTIATION OF ADRENERGIC RECEPTORS*Annals of the New York Academy of Sciences, 1967